BIBA to Release Latest Findings From the Largest Transcatheter Heart Valve Market Investigation

Friday, April 9, 2010 Research News J E 4
LONDON, April 8, 2010 BIBA Research, the UK-based marketresearch specialists for the medical technology industry, announced todaythat the latest findings from their Transcatheter Heart Valve (TAVI) reportwill be released on 26 April. The report covers the data period January-March2010 and is part of BIBA Research's long-established European CardiovascularMonitor.

This monitor on transcatheter heart valve was launched in coincidencewith the TCT Conference in S. Francisco last year and represents the largestthird-party investigation on market trends and penetration of transcatheterheart valve replacement and repair technologies in W. Europe.

This monitor tracks quarterly device consumption from a panel of over 300hospitals in 15 countries and will answer critical questions such as:

Transcatheter (also known as percutaneous) heart valve implantation hasone of the strongest growth potentials in medical technology today. The firstimplantation of an aortic valve in humans was performed by Frenchcardiologist Alain Cribier in 2002. Since then, transcatheter heart valveprocedures have recorded constant double-digit growth on year, as anincreasing number of centres have introduced this programme, offering a newtherapeutic option to candidates not suitable for conventional surgery.

"We are very pleased to enhance our leadership in the market analysisfield of Transcatheter heart valve technology," said Stephen Greenhalgh,BIBA's Managing Director. "This monitor reaches a very large number ofinstitutions and provides valuable information to financial analysts andinvestors. The aim of this service is to provide clients with thekey-information to make strategic decisions."

BIBA also announced that a discussion on transcatheter aortic valvereplacement will be held on Monday 12 April within the Complex Case Reviewsession at the forthcoming edition of Charing Cross International Symposium.The Charing Cross International Symposium, which will be held from 10 to 13April in London, is Europe's longest running and leading vascular congress.This year's edition of Charing Cross is expected to attract over 2,500specialists from 71 countries.

About BIBA Research

BIBA Research is the market research division of BIBA Medical Ltd, theUK-based leading provider of consulting and market analysis services for themedical device industry. BIBA Medical runs 5 newspapers (Vascular News,Cardiovascular News, Spinal News, Interventional News and Cardiac RhythmNews) and a separate conference organizing business branch.

Founded in 1999, BIBA Research is privately owned and has no conflict ofinterest with any medical device company.

Website How fast is the transcatheter heart valve market growing? - What is the transfemoral /transapical procedural split? - Who is winning the market share battle between Medtronic CoreValve and Edwards Sapien? - What is the status of emerging technology platforms?



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Bringing "CLARITY" on Efficacy, Safety and Efficie...
Wyoming Leads Nation in Donor Registration